SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PICCIN, Daniela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.946
EU - Europa 455
AS - Asia 351
OC - Oceania 2
Totale 2.754
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.939
CN - Cina 206
DE - Germania 140
UA - Ucraina 119
SG - Singapore 86
GB - Regno Unito 61
TR - Turchia 52
IT - Italia 30
SE - Svezia 30
FI - Finlandia 28
RU - Federazione Russa 19
BE - Belgio 11
FR - Francia 9
CA - Canada 7
NL - Olanda 3
AU - Australia 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
IN - India 2
IR - Iran 2
BD - Bangladesh 1
CY - Cipro 1
KZ - Kazakistan 1
RO - Romania 1
Totale 2.754
Salva come PNG Salva come JPEG
Città #
Ashburn 346
Woodbridge 277
Fairfield 164
Jacksonville 139
Chandler 131
Houston 129
Ann Arbor 99
Santa Clara 87
Seattle 69
Singapore 69
Wilmington 60
Beijing 54
Cambridge 54
Addison 47
Izmir 44
Nanjing 38
Princeton 27
Milan 23
Boardman 21
San Diego 21
Shanghai 17
Dearborn 16
Shenyang 15
Brussels 11
Kunming 11
Guangzhou 8
Hebei 8
Jiaxing 8
Nanchang 8
New York 8
Jinan 7
Changsha 6
Los Angeles 6
Norwalk 6
San Mateo 6
Leawood 5
Mountain View 5
Redwood City 5
Des Moines 4
Falls Church 4
Tappahannock 4
Tianjin 4
Washington 4
Hangzhou 3
Monmouth Junction 3
Montréal 3
Munich 3
Ardabil 2
Augusta 2
Dublin 2
Hefei 2
Helsinki 2
London 2
Ottawa 2
Prescot 2
Taizhou 2
Toronto 2
Verona 2
Acton 1
Almaty 1
Bremen 1
Brno 1
Changchun 1
Chicago 1
Delhi 1
Dhaka 1
Ferrara 1
Formia 1
Jinhua 1
Kilburn 1
Langfang 1
Lappeenranta 1
Mcallen 1
Messina 1
Mumbai 1
Nicosia 1
Ningbo 1
North Bergen 1
Paris 1
Philadelphia 1
Piscataway 1
Shijiazhuang 1
Wuxi 1
Xi'an 1
Yellow Springs 1
Zhengzhou 1
Totale 2.137
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 342
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 156
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression. 146
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 145
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 143
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines. 127
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 114
miR-15a and miR-16-1 down-regulation in pituitary adenomas 114
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. 111
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 110
null 106
Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. 106
Antiproliferative effects of somatostatin analogs in pituitary adenomas 95
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 93
SHP-1 restrains cell proliferation in human medullary thyroid carcinoma 90
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 88
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 88
Evidence for differential effects of selective somatostatin receptor subtype agonists on alpha-subunit and chromogranin A secretion and on cell viability in human non-functioning pituitary adenomas in vitro 76
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 75
Chemoresistance of Medullary thryroid carcinoma cells is reversed by COX-2 inhibitors in vitro through a PGE2-dependent mechanism 75
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 74
Somatostatin inhibits a medullary thyroid carcinoma cell line growth by activating SHP-1 71
Somatostatin analogs in vitro effects in a growth hormone-releasing hormone (GHRH)-secreting bronchial carcinoid 70
Somatostatin differentially influences proliferation and gene expression by modulating SHP-1 and cAMP pathways in a human medullary thyroid carcinoma cell line 63
SSTR subtypes expression pattern influences the antiproliferative effects of somatostatin and lanreotide on human medullary thyroid carinomas in vitro 61
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro 28
Totale 2.767
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.316
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.316
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020234 0 0 0 0 0 0 43 54 37 54 39 7
2020/2021287 34 29 8 33 12 29 11 32 6 34 49 10
2021/2022330 10 41 31 6 18 12 17 11 10 21 33 120
2022/2023281 28 24 24 35 36 46 24 16 31 1 12 4
2023/2024405 16 28 3 5 12 26 6 273 4 1 0 31
2024/2025203 12 10 44 12 64 61 0 0 0 0 0 0
Totale 2.767